Table 1 Risk factors, EFT, NLR, and VWF among acute ischemic stroke patients and controls
Items | Patients (60) No. (%) | Controls (35) No. (%) | Test χ2 | P value |
|---|---|---|---|---|
Smoking | 19 (31.7) | 9 (25.7) | ||
No smoking | 41 (68.3) | 26 (74.3) | 0.38 | 0.539 |
Hypertension | 25 (41.7) | 12 (34.3) | ||
No hypertension | 35 (58.3) | 23 (65.7) | 0.61 | 0.477 |
DM | 20 (33.3) | 8 (22.9) | ||
No DM | 40 (66.7) | 17 (77.1) | 1.17 | 0.280 |
Hypercholesterolemia | 26 (43.3) | 7 (20.0) | ||
No | 34 (56.7) | 28 (80.0) | 5.31 | 0.021* |
Hyperurecemia | 8 (13.3) | 5 (14.3) | ||
No | 52 (86.7) | 30 (85.7) | 0.02 | 0.896 |
BMI (≥ 25) | 20 (33.7) | 5 (14.3) | ||
Normal BMI(18.5–25) | 40 (66.7) | 30 (85.7) | 4.14 | 0.042* |
AF | 8 (13.3) | 2 (5.7) | ||
No AF | 52 (86.7) | 33 (94.3) | 1.36 | 0.243 |
Carotid stenosis > 50% | 15 (25.0) | 2 (5.7) | ||
No | 45 (75.0) | 33 (94.3) | 5.60 | 0.018* |
Combined risk > 2 | 6 (10.0) | 1 (2.9) | ||
No | 54 (90.0) | 34 (97.1) | 1.65 | 0.199 |
NLR Mean ± SD | 2.20 ± 1.44 | 1.43 ± 0.29 | t = 3.12 | 0.002** |
NLR < 2 | 25 (41.7) | 32 (91.4) | 22.81 | < 0.001* |
NLR ≥ 2 | 35 (58.3) | 3 (8.6) | ||
VWFAg (μml) | 10.90 ± 2.44 | 8.91 ± 1.27 | t = 4.48 | < 0.001* |
EFT (Mean ± SD) | 1.59 ± 0.50 | 1.20 ± 0.41 | t = 3.87 | < 0.001* |
EFT < 5 mm | 25 (41.7) | 28 (80.0) | 13.17 | < 0.001* |
EFT ≥ 5 mm | 35 (58.3) | 7 (20.0) |